MCP-1 inhibitors (Millennium/Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMCP-1 inhibitors (Millennium/Pfizer)
Drug Alias NameMCP-1 inhibitors (LeukoSite/Warner-Lambert)benzimidazoles (LeukoSite/Warner-Lambert)pentadienamides (Millennium/Pfizer)MCP-1 inhibitors (LeukoSite/Pfizer)monocyte chemoattractant protein-1 inhibitors +[12] 
ClassificationSmall molecules
Mechanisms of ActionC-C motif chemokine 2 inhibitorsChemokine receptors antagonists
TargetsC-C motif chemokine 2Chemokine receptors
Therapy Area/IndicationsInflammationAtherosclerosisMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeukosite
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWarner LambertLeukositePfizer Inc +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationAtherosclerosisMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A